BCG Henderson Institute

Generic filters

François Candelon

Global Director, BCG Henderson Institute



  • Engineering degree, École Polytechnique and MINES Paris Tech

BHI Affiliation

François Candelon

Global Director, BCG Henderson Institute

François Candelon is the Global Director of BHI based in BCG’s Paris office and a Managing Director & Senior Partner. He also leads BHI’s Tech & Biz Lab focused on exploring the technology horizon and sharing actionable insights with leaders. 

François’ research is focused on AI and Digital as a source of competitive advantage for businesses, national economies, and current research themes include topics such as AI competitivenessdeep tech, and AI & society.

His work has appeared in publications such as Harvard Business Review, MIT Sloan Management Review, Strategy Science, TED. He writes a monthly column on AI in Fortune and he has been a speaker at global conferences like Politico, AI Summit, MWC, TED, Web Summit, Global AI Summit, and Wuzhen Internet Conference. In 2021, he was among the 8 shortlisted for the prestigious Thinkers50 distinguished Digital Award.

Outside of work, Francois enjoys sports, karate, contemporary art, and theater.

Recent Work

View All

BCG Henderson Institute | March 14, 2023

How CEOs Can Evaluate New Generative AI Models

As GPT-4 and other new models are released, leaders need to constantly assess the implications for their business. | March 7, 2023

The CEO’s Guide to the Generative AI Revolution

This powerful technology has the potential to disrupt nearly every industry, promising both competitive advantage and creative destruction. Here’s how to strategize for that future.

Fortune | March 3, 2023

Four Steps to Building a Synthetic Biology Strategy

Incumbents in many industries are experimenting with syn-bio engagement strategies. However, they can’t rely solely on traditional buying and selling relationships because the syn-bio ecosystem in still very nascent. | February 15, 2023

What’s Your Synthetic Biology Strategy?

By analyzing the syn-bio industry stack and understanding its dynamics, incumbents can develop strategies that will gain them competitive advantage.

BCG Henderson Institute | February 9, 2023

How to Unlock Hidden Value from Generative AI

Prompt engineering is only the beginning—it’s time to start experimenting.

Fortune | February 3, 2023

In Synthetic Biology, Startups And Incumbent Companies Should Be Partners, Not Foes

Advances in syn-bio depend on incumbent companies and startups working together and leveraging each others' strengths, only then can both generate all the benefits that the science promises.